MwanzoEXEL • NASDAQ
add
Exelixis Inc
Bei iliyotangulia
$ 34.50
Bei za siku
$ 34.10 - $ 36.19
Bei za mwaka
$ 20.02 - $ 36.97
Thamani ya kampuni katika soko
10.29B USD
Wastani wa hisa zilizouzwa
1.94M
Uwiano wa bei na mapato
22.95
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 539.54M | 14.33% |
Matumizi ya uendeshaji wa biashara | 334.37M | -28.97% |
Mapato halisi | 117.97M | 11,232.66% |
Kiwango cha faida halisi | 21.87 | 9,840.91% |
Mapato kwa kila hisa | 0.47 | 370.00% |
EBITDA | 195.30M | 1,830.28% |
Asilimia ya kodi ya mapato | 23.77% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.19B | 7.77% |
Jumla ya mali | 2.96B | -0.56% |
Jumla ya dhima | 684.86M | 8.83% |
Jumla ya hisa | 2.28B | — |
hisa zilizosalia | 285.58M | — |
Uwiano wa bei na thamani | 4.33 | — |
Faida inayotokana na mali | 16.38% | — |
Faida inayotokana mtaji | 19.62% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 117.97M | 11,232.66% |
Pesa kutokana na shughuli | 271.34M | 131.19% |
Pesa kutokana na uwekezaji | -217.15M | -726.05% |
Pesa kutokana na ufadhili | 5.70M | 102.59% |
Mabadiliko halisi ya pesa taslimu | 59.89M | 188.56% |
Mtiririko huru wa pesa | 302.21M | 913.29% |
Kuhusu
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
15 Nov 1994
Makao Makuu
Tovuti
Wafanyakazi
1,310
